These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 18054395)

  • 41. Convergent immunological solutions to Argentine hemorrhagic fever virus neutralization.
    Zeltina A; Krumm SA; Sahin M; Struwe WB; Harlos K; Nunberg JH; Crispin M; Pinschewer DD; Doores KJ; Bowden TA
    Proc Natl Acad Sci U S A; 2017 Jul; 114(27):7031-7036. PubMed ID: 28630325
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [New transmission scenarios of the Argentine hemorrhagic fever since the introduction of the live attenuated junin virus vaccine (Candid #1): an experience in migrant workers].
    Briggiler A; Sinchi A; Coronel F; Sánchez Z; Levis S; Taylor J; Enria D
    Rev Peru Med Exp Salud Publica; 2015; 32(1):165-71. PubMed ID: 26102120
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of immunosuppression on experimental Argentine hemorrhagic fever in guinea pigs.
    Kenyon RH; Green DE; Peters CJ
    J Virol; 1985 Jan; 53(1):75-80. PubMed ID: 2981364
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Importance of dose of neutralising antibodies in treatment of Argentine haemorrhagic fever with immune plasma.
    Enria DA; Briggiler AM; Fernandez NJ; Levis SC; Maiztegui JI
    Lancet; 1984 Aug; 2(8397):255-6. PubMed ID: 6146809
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ribavirin prophylaxis and therapy for experimental argentine hemorrhagic fever.
    McKee KT; Huggins JW; Trahan CJ; Mahlandt BG
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1304-9. PubMed ID: 2848441
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Monoclonal Antibodies with Neutralizing Activity and Fc-Effector Functions against the Machupo Virus Glycoprotein.
    Amanat F; Duehr J; Huang C; Paessler S; Tan GS; Krammer F
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31801871
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Argentine hemorrhagic fever. Alterations of the complement system and anti-Junin-virus humoral response.
    de Bracco MM; Rimoldi MT; Cossio PM; Rabinovich A; Maiztegui JI; Carballal G; Arana RM
    N Engl J Med; 1978 Aug; 299(5):216-21. PubMed ID: 207985
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Candid No. 1 Argentine hemorrhagic fever vaccine protects against lethal Junin virus challenge in rhesus macaques.
    McKee KT; Oro JG; Kuehne AI; Spisso JA; Mahlandt BG
    Intervirology; 1992; 34(3):154-63. PubMed ID: 1338783
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidemiology of Argentine hemorrhagic fever.
    Carballal G; Videla CM; Merani MS
    Eur J Epidemiol; 1988 Jun; 4(2):259-74. PubMed ID: 2841151
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IgG subclasses in human immune response to wild and attenuated (vaccine) Junin virus infection.
    del Carmen Saavedra M; Sottosanti JM; Riera L; Ambrosio AM
    J Med Virol; 2003 Mar; 69(3):447-50. PubMed ID: 12526057
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunofluorescent anti-Junin virus antibodies in Argentine hemorrhagic fever.
    Cossio PM; Rabinovich A; Maiztegui JI; Carballal G; Casanova MB; Ritacco V; Arana RM
    Intervirology; 1979; 12(1):26-31. PubMed ID: 227813
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protection of Junín virus-infected marmosets by passive administration of immune serum: association with late neurologic signs.
    Avila MM; Samoilovich SR; Laguens RP; Merani MS; Weissenbacher MC
    J Med Virol; 1987 Jan; 21(1):67-74. PubMed ID: 3025358
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Experimental biology and pathogenesis of Junin virus infection in animals and man.
    Weissenbacher MC; de Guerrero LB; Boxaca MC
    Bull World Health Organ; 1975; 52(4-6):507-15. PubMed ID: 182401
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bivalent Junin & Machupo experimental vaccine based on alphavirus RNA replicon vector.
    Johnson DM; Jokinen JD; Wang M; Pfeffer T; Tretyakova I; Carrion R; Griffiths A; Pushko P; Lukashevich IS
    Vaccine; 2020 Mar; 38(14):2949-2959. PubMed ID: 32111526
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protection of guinea pigs against experimental Argentine hemorrhagic fever by purified human IgG: importance of elimination of infected cells.
    Kenyon RH; Condie RM; Jahrling PB; Peters CJ
    Microb Pathog; 1990 Oct; 9(4):219-26. PubMed ID: 1965845
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cross-protection between Tacaribe complex viruses. Presence of neutralizing antibodies against Junin virus (Argentine hemorrhagic fever) in guinea pigs infected with Tacaribe virus.
    Weissenbacher MC; Coto CE; Calello MA
    Intervirology; 1975-1976; 6(1):42-9. PubMed ID: 178627
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Junin virus activity in rodents from endemic and nonendemic loci in central Argentina.
    Mills JN; Ellis BA; McKee KT; Ksiazek TG; Oro JG; Maiztegui JI; Calderon GE; Peters CJ; Childs JE
    Am J Trop Med Hyg; 1991 Jun; 44(6):589-97. PubMed ID: 1650148
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical and epidemiological patterns of Argentine haemorrhagic fever.
    Maiztegui JI
    Bull World Health Organ; 1975; 52(4-6):567-75. PubMed ID: 1085212
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effective Population Size Differences in
    Chiappero MB; Piacenza MF; Provensal MC; Calderón GE; Gardenal CN; Polop JJ
    Am J Trop Med Hyg; 2018 Aug; 99(2):445-450. PubMed ID: 29893205
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Phenotypic markers of attenuation in Junin virus strains recently isolated from individuals vaccinated with Junin Candid#1 strain].
    Gamboa GS; Ambrosio AM; Maiza AS; Mariani M; Rodrigues Garcia Armôa G; Saavedra Mdel C
    Medicina (B Aires); 2013; 73(4):303-9. PubMed ID: 23924527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.